-
Mashup Score: 37
Inclisiran, an siRNA therapy, consistently reduces low-density lipoprotein cholesterol (LDL-C) with twice-yearly dosing. Potential cardiovascular bene…
Source: www.sciencedirect.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 54
Patients with heterozygous familial hypercholesterolemia (HeFH) often cannot reach guideline-recommended low-density lipoprotein cholesterol (LDL-C) g…
Source: www.sciencedirect.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 54
Patients with heterozygous familial hypercholesterolemia (HeFH) often cannot reach guideline-recommended low-density lipoprotein cholesterol (LDL-C) g…
Source: www.sciencedirect.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 42
Patients with heterozygous familial hypercholesterolemia (HeFH) often cannot reach guideline-recommended low-density lipoprotein cholesterol (LDL-C) g…
Source: www.sciencedirect.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 56Calls to test babies for gene fault that makes cholesterol rocket - 4 month(s) ago
Toddlers with a common genetic fault can have ‘hidden’ cholesterol levels twice an adult, putting them at risk of heart attacks and strokes. Rianna Wingett, died of a heart attack age 11.
Source: www.dailymail.co.ukCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 16Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial - 5 month(s) ago
Statins reduce LDL cholesterol and cardiovascular events among those with or without diabetes but have been reported to increase new-onset diabetes. T…
Source: www.sciencedirect.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 37Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials - 6 month(s) ago
Among patients with prior myocardial infarction (MI), the risk of future ischaemic cardiovascular events is increased, and intensive lipid-lowering th…
Source: www.sciencedirect.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 8The evolving need and challenges to reach LDL-c targets in high-risk patients - PACE-CME - 8 month(s) ago
According to the latest registries the majority of high- and very high-risk patients do not accieve 2019 ESC/EAS recommended LDL-c goals. Kausik Ray discusses how LDL-c goal attainment can be improved.
Source: pace-cme.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 18
Original Article from The New England Journal of Medicine — Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
Source: www.nejm.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Inclisiran and cardiovascular events: a patient-level analysis of phase III trials - 10 month(s) ago
Exploratory findings from a patient-level, pooled analysis of the pivotal Phase III ORION trials (−9, −10, and −11) suggest that treatment with a 6 monthly dosi
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet
What do we mean when we use the term population health? Here we estimate through quantifiable measures of risk events in people with ASCVD. An intervention at the level of the health care system, bringing the system, patients and physicians together https://t.co/gRjqz5QYI8